Register
Login:
Share:
Email Facebook Twitter

Add Summit Corp to quick picks

Summit Corp Share Price (SUMM)



Share Price Information for Summit Corp (SUMM)


Share Price: 143.50Bid: 142.00Ask: 145.00Change: 0.00 (0.00%)No Movement on Summit Corp
Spread: 3.00Spread as %: 2.11%Open: 138.50High: 144.00Low: 138.50Yesterday’s Close: 143.50
InfoCFDs vs Share Trading - Download your Free Guide from LSE Markets
When trading CFDs, Forex, and Spread bets, it is possible to lose more than your initial deposit.


Summit Corporation Plc Ord 1P

Summit Corp is listed in the FTSE AIM All-Share
Summit Corp is part of the Pharmaceuticals & Biotechnology sector




Intraday Summit Corp Share Chart


Intraday Summit Corp Share Price Chart


Share Price SpacerPrice
143.50

Share Price SpacerBid
142.00

Share Price SpacerAsk
145.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
113,029

Share Price SpacerOpen
138.50

Share Price SpacerHigh
144.00

Share Price SpacerLow
138.50

Share Price SpacerClose
143.50

Share Price SpacerCurrency
GBX

3 Month Summit Corp Share Graph


3 Month Summit Corp Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 41.06m £58.92m 2,500

52 Week High 149.75 52 Week High Date 18-AUG-2014
52 Week Low 6.25 52 Week Low Date 27-MAY-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
26 42,521 60,508 -4.815 -29.80 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Aug-14
16:22:31
143.00
20,000
Sell* 
143.00
145.00
28.60k
Trade Type:
Ordinary

22-Aug-14
16:17:48
145.00
3,538
Buy* 
143.00
145.00
5,130
Trade Type:
Ordinary

22-Aug-14
10:43:29
143.00
25,000
Sell* 
143.00
145.00
35.75k
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Summit Corp trades >>

Directors Deals for Summit Corp (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
29-Jul-14Buy
Trade Notifier Information for Summit Corporation
Glyn Edwards held the position of CEO at Summit Corporation at the time of this trade.
 Glyn Edwards
104.5GBX30,000233333
23-Jul-13Placing
Trade Notifier Information for Summit Corporation
Frank Armstrong held the position of Non-Executive Director at Summit Corporation at the time of this trade.
 Frank Armstrong
5GBX50,00050000
23-Jul-13Placing
Trade Notifier Information for Summit Corporation
Jim Mellon held the position of Non-Executive Director at Summit Corporation at the time of this trade.
 Jim Mellon
5GBX20,000,00045000001
View more Summit Corp directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Fri 16:47
Phooka
Still only 7.17p in Old Money
143.50
No Opinion

Don't get over excited guy's. Yes it's nice to finish the week on an up and also that the SP is going in the right direction but come on... This should be way ahead of here by now. I know Biotech's take a long time but I've been here over 3 years now and am still 35% down. Maybe the day traders aren't so mad after all. Guess more patience is required. Onwards and upwards. Have a good weekend all.
Fri 16:29
English_Parisien
It just went bananas ?!
144.00
No Opinion

2x 25k and 1x20k = nearly £100k of what I would hope are buys ?! GLA - EP
Fri 11:49
Sheephatch
SUMM
141.00
No Opinion

More big buys yesterday late afternoon. Pressure back on this morning. Great week. Well done SUMM. Very exiting few months ahead.
Fri 09:00
gmcc
RE: SMTC1100 Phase 1b - dietary new..
138.50
No Opinion

Hi AMM, Summit did advise 18th July e-mail reply : “We hope to be in a position to provide more clarity about the future trial plans for SMT C1100 around September time with the aim of dosing patients during the fourth quarter. Cannot really add to that at this time. “ As mentioned by Chrisatrdg : Canaccord presentation 13th August 2014 : still mentions “ Next patient trial expected to start Q4 2014 “ Yes , need clarity on how they plan to test the new SMTC1100 recipe actually works : Phase1b trial still open so they might invite the same boys to retake the new dose ! Takes time to get clearance from regulatory authorities to proceed with new trials, let alone set up the programme perhaps in different countries . Approx. 17 weeks left before year end for the announcement we all wish to see “ first DMD patient dosed in phase 2 trial etc “ The other possible option to proceed with phase 2 using the same drug used in phase1b , might be problematic to effectively manage patients dietary food intake , much larger population involved across international sites , so preferable for many reasons that absorption blood issue resolved ! Good luck everyone
Fri 07:37
Chrisatrdg
SMTC1100
138.50
Strong Buy

I understand the next trials are in Qtr 4 2014 based on last presentation by Summit but we do not know if it is phase 1C or phase 1B contd or what.The SP will be determined when we know i.e. how have they decided to deal with the absorption issue. Expect interim results hopefully by mid Sept at which point there maybe an RNS for DMD trials.Remember Qtr 4 is from Oct to Dec so maybe we still have to wait a while.I am hoping for something good will come out of the interim results in Sept which will support the current SP otherwise we could continue to go back down.GLA
Thu 17:55
AppleMacMan
SMTC1100 Phase 1b - dietary news
138.50
No Opinion

I wonder when we can expect some news of proposals to address the Phase 1b dietary issue? Also if (as was mentioned at the AGM,) Phase 2 is still on schedule?

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Summit Corp (SUMM) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs




Sign up for Live Prices


CD02WL.001.081313
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.